Cargando...
Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma
The alteration of the epidermal growth factor receptor (EGFR)-driven signaling network is a characteristic feature of glioblastomas (GBM), and its inhibition represents a treatment strategy. However, EGFR-targeted interventions have been largely ineffective. Complex perturbations in this system are...
Guardado en:
| Publicado en: | Cell Commun Signal |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4391485/ https://ncbi.nlm.nih.gov/pubmed/25885672 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-015-0098-6 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|